Expression of the fusogenic p14 FAST protein from a replication-defective adenovirus vector does not provide a therapeutic benefit in an immunocompetent mouse model of cancer

导出原文传递

翻译打印收藏纠错

作者： Wong, C. M. ^[1] ; Nash, L. A. ^[2] ; Del Papa, J. ^[3] ; Poulin, K. L. ; Falls, T. ; Bell, J. C. ; Parks, R. J.

作者单位： Ottawa Hosp, Res Inst, Regenerat Med Program, 501 Smyth Rd,Room C4115, Ottawa, ON K1H 8L6, Canada ^[1] Ottawa Hosp, Res Inst, Canc Therapeut Program, Ottawa, ON, Canada ^[2] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada ^[3]

发布时间 2017-04-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cancer gene therapy

2016年23卷10期

355-364页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Expression of the fusogenic p14 FAST protein from a replication-defective adenovirus vector does not provide a therapeutic benefit in an immunocompetent mouse model of cancer

Cancer gene therapy

相似文献

Cancer gene therapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Expression of the fusogenic p14 FAST protein from a replication-defective adenovirus vector does not provide a therapeutic benefit in an immunocompetent mouse model of cancer

Cancer gene therapy

相似文献

Cancer gene therapy

相关期刊

检索历史清除